Although their analysis incorporated a binary classification of T2D duration, it did not include other patient characteristics, such as insulin use, diabetes medication use, and glycemic control, that differentiate T2D response to bariatric surgery. The gene discussed is INS; the disease is type 2 diabetes mellitus.